Human breast cancer. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy15

Breast Cell Line, Tumor Tumor Cells, Cultured MCF-7 Cells Mammary Glands, Human Epithelial Cells Cell Line Axilla Neoplastic Stem Cells Mammary Glands, Animal Lymph Nodes Nipples Cell Nucleus Neoplastic Cells, Circulating Milk, Human

Organisms4

Mice, Nude Mice, SCID Mammary Tumor Virus, Mouse Mice, Inbred BALB C

Diseases38

Breast Neoplasms Carcinoma, Ductal, Breast Neoplasm Invasiveness Neoplasm Metastasis Breast Diseases Mammary Neoplasms, Experimental Neoplasms, Hormone-Dependent Carcinoma, Intraductal, Noninfiltrating Carcinoma, Lobular Carcinoma Breast Neoplasms, Male Lymphatic Metastasis Mammary Neoplasms, Animal Fibrocystic Breast Disease Disease Progression Genetic Predisposition to Disease Cell Transformation, Neoplastic Ovarian Neoplasms Neoplasm Recurrence, Local Lung Neoplasms Carcinoma, Ductal Bone Neoplasms Neoplasms Carcinoma in Situ Prostatic Neoplasms Adenocarcinoma Neovascularization, Pathologic Colonic Neoplasms Fibroadenoma Triple Negative Breast Neoplasms Stomach Neoplasms Neoplasms, Basal Cell Neoplasms, Second Primary Adenofibroma Inflammatory Breast Neoplasms Neoplastic Cells, Circulating Pancreatic Neoplasms Disease Models, Animal

Chemicals and Drugs77

Receptors, Estrogen Tamoxifen Receptor, erbB-2 Receptors, Progesterone Neoplasm Proteins Estrogen Antagonists Antineoplastic Agents Tumor Markers, Biological Estrogen Receptor alpha Estrogens Estradiol Antineoplastic Agents, Hormonal RNA, Messenger DNA, Neoplasm Estrogen Receptor Modulators RNA, Small Interfering BRCA1 Protein RNA, Neoplasm BRCA2 Protein Aromatase Inhibitors Tumor Suppressor Protein p53 Receptor, Epidermal Growth Factor Antibodies, Monoclonal Antigens, CD24 Antibodies, Monoclonal, Humanized Antineoplastic Agents, Phytogenic Selective Estrogen Receptor Modulators Doxorubicin Tumor Suppressor Proteins Fluorouracil Transcription Factors Paclitaxel Promegestone Cyclin D1 Anticarcinogenic Agents Nitriles Antigens, Neoplasm Proto-Oncogene Proteins Mucin-1 Proto-Oncogene Proteins c-akt Ki-67 Antigen Cyclophosphamide Epirubicin Antibiotics, Antineoplastic Estrogen Receptor beta DNA-Binding Proteins Proto-Oncogene Proteins c-bcl-2 Cathepsin D Progestins Receptors, Estradiol Enzyme Inhibitors Neuregulin-1 MicroRNAs Protein-Serine-Threonine Kinases Cadherins DNA Primers Apolipoproteins D Nuclear Proteins Nafoxidine Triazoles Receptor, erbB-3 Phosphatidylinositol 3-Kinases Plant Extracts Withanolides Cancer Vaccines Antigens, CD44 Nuclear Receptor Coactivator 3 Epidermal Growth Factor Estrone Aromatase Carrier Proteins Cyclin-Dependent Kinase Inhibitor p21 Membrane Proteins Methotrexate Cell Cycle Proteins Apoptosis Regulatory Proteins Prolactin

Analytical, Diagnostic and Therapeutic Techniques and Equipment69

Mammary Neoplasms, Experimental Prognosis Mammography Immunohistochemistry Transplantation, Heterologous Neoplasm Transplantation Reverse Transcriptase Polymerase Chain Reaction Neoplasm Staging Gene Expression Profiling Mastectomy Blotting, Western Early Detection of Cancer Xenograft Model Antitumor Assays Risk Factors Chemotherapy, Adjuvant Antineoplastic Combined Chemotherapy Protocols Survival Analysis Transfection Disease-Free Survival Case-Control Studies Follow-Up Studies Survival Rate Breast Self-Examination Oligonucleotide Array Sequence Analysis Risk Drug Screening Assays, Antitumor Prospective Studies Retrospective Studies Risk Assessment Treatment Outcome Immunoenzyme Techniques Tumor Burden Tissue Array Analysis Mastectomy, Segmental Odds Ratio Incidence Polymerase Chain Reaction Multivariate Analysis Cohort Studies Sensitivity and Specificity Gene Knockdown Techniques Kaplan-Meier Estimate Registries Flow Cytometry Predictive Value of Tests Ultrasonography, Mammary Tumor Stem Cell Assay Reproducibility of Results Combined Modality Therapy SEER Program Neoplasm Grading Questionnaires Logistic Models Breast Implants Biopsy Models, Biological Mammaplasty In Situ Hybridization, Fluorescence Neoadjuvant Therapy Molecular Targeted Therapy Mass Screening Immunoblotting Radiotherapy, Adjuvant Confidence Intervals Proportional Hazards Models Clinical Trials as Topic Disease Models, Animal Genetic Testing Drug Administration Schedule

Psychiatry and Psychology2

Breast Feeding Breast Self-Examination

Phenomena and Processes51

Gene Expression Regulation, Neoplastic Cell Proliferation Cell Division Drug Resistance, Neoplasm Apoptosis Genes, erbB-2 Genes, BRCA1 Signal Transduction Postmenopause Transfection Cell Cycle Premenopause Cell Movement Genetic Predisposition to Disease Breast Feeding Down-Regulation Menopause Cell Growth Processes Time Factors Cell Survival Risk Promoter Regions, Genetic Dose-Response Relationship, Drug Mutation Gene Amplification Up-Regulation Genes, BRCA2 Phosphorylation Gene Expression RNA Interference Base Sequence Odds Ratio DNA Methylation Gene Silencing Sensitivity and Specificity Drug Synergism Phenotype Transcription, Genetic Genes, Tumor Suppressor Genotype Epithelial-Mesenchymal Transition Polymorphism, Genetic Germ-Line Mutation Genes, Neoplasm Genes, p53 Enzyme Activation Cell Adhesion Tumor Microenvironment Parity Protein Binding Alleles

Disciplines and Occupations1

Immunohistochemistry

Technology, Industry, Agriculture1

Information Science7

Survival Rate Base Sequence Incidence Molecular Sequence Data Registries SEER Program Questionnaires

Named Groups2

Survivors European Continental Ancestry Group

Health Care30

Risk Factors Survival Analysis Disease-Free Survival Case-Control Studies Follow-Up Studies Survival Rate Risk Prospective Studies Age Factors Retrospective Studies Risk Assessment Treatment Outcome Odds Ratio Incidence Multivariate Analysis Cohort Studies Sensitivity and Specificity Kaplan-Meier Estimate Registries Predictive Value of Tests Reproducibility of Results SEER Program Questionnaires Logistic Models Mass Screening Confidence Intervals Parity Proportional Hazards Models Clinical Trials as Topic Genetic Testing

Geographicals1

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Psychiatry and Psychology Phenomena and Processes Disciplines and Occupations Information Science Named Groups Health Care Geographicals

Breast Neoplasms Breast Cell Line, Tumor Receptors, Estrogen Carcinoma, Ductal, Breast Gene Expression Regulation, Neoplastic Tamoxifen Receptor, erbB-2 Tumor Cells, Cultured Receptors, Progesterone Neoplasm Invasiveness Neoplasm Metastasis MCF-7 Cells Breast Diseases Mice, Nude Neoplasm Proteins Mammary Neoplasms, Experimental Estrogen Antagonists Antineoplastic Agents Tumor Markers, Biological Estrogen Receptor alpha Estrogens Prognosis Cell Proliferation Neoplasms, Hormone-Dependent Estradiol Mammography Cell Division Antineoplastic Agents, Hormonal RNA, Messenger Drug Resistance, Neoplasm Immunohistochemistry Carcinoma, Intraductal, Noninfiltrating Apoptosis Transplantation, Heterologous Neoplasm Transplantation Reverse Transcriptase Polymerase Chain Reaction Carcinoma, Lobular Carcinoma Mammary Glands, Human Neoplasm Staging Breast Neoplasms, Male Gene Expression Profiling Genes, erbB-2 Mastectomy Genes, BRCA1 Blotting, Western DNA, Neoplasm Signal Transduction Early Detection of Cancer Xenograft Model Antitumor Assays Estrogen Receptor Modulators Lymphatic Metastasis Postmenopause Risk Factors Mammary Neoplasms, Animal Chemotherapy, Adjuvant RNA, Small Interfering Antineoplastic Combined Chemotherapy Protocols Survival Analysis Transfection Cell Cycle BRCA1 Protein Premenopause Fibrocystic Breast Disease Cell Movement Disease Progression Genetic Predisposition to Disease RNA, Neoplasm Disease-Free Survival Breast Feeding Down-Regulation Menopause Case-Control Studies Cell Growth Processes Cell Transformation, Neoplastic Ovarian Neoplasms Neoplasm Recurrence, Local Time Factors Lung Neoplasms Carcinoma, Ductal BRCA2 Protein Aromatase Inhibitors Bone Neoplasms Follow-Up Studies Cell Survival Survival Rate Breast Self-Examination Oligonucleotide Array Sequence Analysis Risk Tumor Suppressor Protein p53 Promoter Regions, Genetic Receptor, Epidermal Growth Factor Antibodies, Monoclonal Dose-Response Relationship, Drug Neoplasms Mutation Mice, SCID Gene Amplification Epithelial Cells

No FAQ available that match "human breast cancer"